Georg Schett
Rheumatology · 2007–2022
A researcher in the Science corpus: 15 papers; trusts 6 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Rheumatology — 74 citations into it; #38 of 221 by trust here, #46 by citations
- Immunology — 65 citations into it
- Molecular Biology — 65 citations into it
- Oncology — 37 citations into it; #300 of 1,698 by trust here, #859 by citations
- Radiology, Nuclear Medicine and Imaging — 10 citations into it
Whom Georg Schett trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Georg Schett overall
Papers from Georg Schett's perspective
Ordered by how strongly the researchers Georg Schett trusts endorse each paper. Same corpus, a different order for every researcher.
- Evolving concepts of rheumatoid arthritis (Nature)
- Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system (Nature Immunology)
- Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. (Arthritis & Rheumatism)
- Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis (Science)
- IL-1 mediates TNF-induced osteoclastogenesis. (Journal of Clinical Investigation)
- Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells (Nature Immunology)
- IL-17 family cytokines and the expanding diversity of effector T cell lineages. (Annual Review of Immunology)
- LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. (Cell)
- Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling (Nature)
- The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. (New England Journal of Medicine)
Their papers
- Dickkopf-1 is a master regulator of joint remodeling (2007) — 1,345 citations
- Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022) — 845 citations
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020) — 807 citations
- Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis (2018) — 639 citations
- Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss (2018) — 652 citations
- Pathogenetic insights from the treatment of rheumatoid arthritis. (2017) — 1,136 citations
- Trial of Tocilizumab in Giant‐Cell Arteritis (2017) — 1,122 citations
- European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (2015) — 893 citations
- Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines (2014) — 913 citations
- Human polymorphism at microRNAs and microRNA target sites. (2013) — 605 citations
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis (2012) — 830 citations
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. (2012) — 705 citations
- Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment (2012) — 890 citations
- The pathogenesis of rheumatoid arthritis. (2011) — 2,726 citations
- Cytokines in the pathogenesis of rheumatoid arthritis (2007) — 2,626 citations